Radiation Adherence/Toxicity in Patients With Non-Ovarian Gynecological Cancers

NCT ID: NCT02003430

Last Updated: 2018-01-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

15 participants

Study Classification

OBSERVATIONAL

Study Start Date

2013-09-30

Study Completion Date

2017-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to investigate the association between the Independent Activities of Daily Living (I-ADL) component of the Comprehensive Geriatric Assessment (CGA) and poor tolerance to radiation treatment in older and younger patients with non-ovarian gynecological cancers.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

There are little data regarding the impact of functional age on tolerance to radiotherapy for gynecologic cancers. A comprehensive geriatric assessment (CGA) tool which measures functional status (including the Instrumental Activities of Daily Living (I-ADL)), among many other important geriatric related conditions, was developed by Hurria and colleagues. Geriatric assessment variables including functional status predicted for toxicity in older patients receiving chemotherapy and surgery for multiple cancer types., 2 We hypothesize that I-ADL can be used to predict treatment tolerance in patients of all ages receiving pelvic and/or paraaortic region radiation therapy for gynecologic malignancies.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Non-ovarian Gynecological Cancers

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

≥65 years old

20 patients greater than or equal to 65 years of age

No interventions assigned to this group

<65 years old

20 patients less than 65 years of age

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* ≥Age 18 years (no upper age limit)
* Diagnosis of cervical, vaginal, vulvar, or endometrial cancer with either pelvic radiotherapy or chemoradiotherapy planned as part of standard treatment.
* Consented for receipt of External Beam Radiation Therapy (EBRT) at the University of North Carolina Chapel Hill
* Ability to read English (required for CGA)
* Curative treatment intent as defined by their radiation oncologist
* Negative serum pregnancy test in women of childbearing potential

Exclusion Criteria

* \< Age 18 years
* Incurable cancer as defined by their radiation oncologist
* Planned radiation for palliative intent only
* Inability to complete the I-ADL section of the CGA
* Prior radiation to areas targeted by radiotherapy within this study
* Other active, invasive malignancy requiring active ongoing therapy during their radiotherapy with the exception of:
* Localized squamous cell carcinoma of the skin
* Basal-cell carcinoma of the skin
* Other malignancies requiring locally ablative therapy only
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

UNC Lineberger Comprehensive Cancer Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mahesh Varia, MD, ChB

Role: PRINCIPAL_INVESTIGATOR

Department of Radiation Oncology, University of North Carolina Chapel Hill

Noam VanderWalde, MD

Role: STUDY_DIRECTOR

Department of Radiation Oncology, Unverisity of North Carolina Chapel Hill

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

UNC Department of Radiation Oncology Clinic

Chapel Hill, North Carolina, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

LCCC1321

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Curatively Intended Thoracic Reirradiation
NCT06950073 NOT_YET_RECRUITING